| Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges M Olivi, F Di Biase, G Lanzarone, G Arrigo, F Martella, V Apolito, ... Current Treatment Options in Oncology 24 (6), 693-710, 2023 | 7 | 2023 |
| Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents … V Apolito, G Arrigo, L Vasseur, M Olivi, S Perrone, V Giai, C Secreto, ... British journal of haematology 203 (4), e98-e101, 2023 | 2 | 2023 |
| PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE+/-ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY. F Catania, C Frairia, M Olivi, M Festuccia, D Rapezzi, B Nicolino, G Arrigo, ... HemaSphere 7 (S3), e214549f, 2023 | | 2023 |
| PB1864: IMPROVED LONG-TERM SURVIVAL OF ELDERLY ADULTS WITH AML RECEIVING INTENSIVE INDUCTION THERAPY FOLLOWED BY EITHER ALLOGENEIC STEM CELL TRANSPLANT OR MAINTENANCE … FDI Biase, G Lanzarone, E Beggiato, L Giaccone, M Olivi, V Apolito, ... HemaSphere 7 (S3), e961629b, 2023 | | 2023 |
